glaxosmithkline (GSK)'s liquid meningitis vaccine Menveo has been approved by the European Commission and can be marketed in the European Union. The British pharmaceutical company stated on Wednesday that this fully liquid vaccine helps simplify the vaccination process for invasive meningococcal disease (IMD) by providing healthcare providers with an option that does not require reconstitution before use.
葛兰素史克的液体脑膜炎疫苗获欧盟批准
glaxosmithkline's liquid meningitis vaccine has been approved by the European Union.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated